InvestLog
NVCR logo

NVCR

NovoCure LimitedNASDAQHealthcare
$10.55-2.68%ClosedMarket Cap: $1.20B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-02-26HC Wainwright & Co.—Buy—
2026-01-15Wedbush—Neutral—
2026-01-13HC Wainwright & Co.—Buy—
2025-10-30HC Wainwright & Co.—Buy—
2025-10-27JP Morgan—Neutral—
2025-07-25Wells Fargo—Equal Weight—
2025-06-27Piper Sandler—Overweight—
2025-04-23Piper Sandler—Overweight—
2025-04-16Wedbush—Neutral—
2025-04-10JP Morgan—Neutral—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-1.17$757.9M6
Sun Dec 31$-0.42$915.6M3
Mon Dec 31$2.45$1.52B1
Tue Dec 31$4.79$1.84B1